Poverty, Migration, and Chagas Disease-Reference-Cited by-同舟云学术

Poverty, Migration, and Chagas Disease

Published:2021-01-11 Issue:1 Volume:8 Page:52-58
ISSN:2196-3045
Container-title:Current Tropical Medicine Reports
language:en
Short-container-title:Curr Trop Med Rep

Author:

Guhl Felipe^ORCID,Ramírez Juan David

Funder

Facultad de Ciencias, Universidad de los Andes

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s40475-020-00225-y.pdf

Reference39 articles.

1. Guhl F, Jaramillo C, Vallejo G, Cárdenas A-Arroyo F, Aufderheide A. Chagas disease and human migration. Mem Inst Oswaldo Cruz. 2000;95:553–5.

2. Coura J, Borges-Pereira J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop. 2010;115:5–13.

3. (2020) Sector rural y desarrollo local en América Latina y el Caribe (América Latina y el Caribe). In: Ilo.org. https://www.ilo.org/americas/temas/sector-rural-y-desarrollo-local/lang%2D%2Des/index.htm. .

4. (2020) WHO | 6 February 2015, vol. 90, 6 (pp. 33–44). In: Who.int. https://www.who.int/wer/2015/wer9006/en/. .

5. Schmunis G. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007;102:75–86.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zoonotic Cycle of American Trypanosomiasis in an Endemic Region of the Argentine Chaco, Factors That Influenced a Paradigm Shift;Insects;2024-06-25

2. Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance;Expert Review of Anti-infective Therapy;2024-05-31

3. Enzymatic Synthesis of Austroeupatol Esters with Enhanced Antiprotozoal Activity;ACS Medicinal Chemistry Letters;2024-05-30

4. Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status;Expert Opinion on Investigational Drugs;2024-05-14

5. Saturated Iso-Type Fatty Acids from the Marine Bacterium Mesoflavibacter zeaxanthinifaciens with Anti-Trypanosomal Potential;Pharmaceuticals;2024-04-13